• Press Release

The BioIndustry Association announces 2021 charity partnership with Ovarian Cancer Action

The BioIndustry Association (BIA) is proud to be working with Ovarian Cancer Action as its charity partner for 2021. One woman dies in the UK from ovarian cancer every two hours and although five-year survival rates for ovarian cancer are improving, other cancers, such as breast cancer, had better survival rates two generations ago than ovarian cancer does today.

UK in spotlight at JP Morgan Healthcare conference 2021 with the largest acquisition of a privately listed UK biotech company on record

The largest acquisition of a private UK biotech company on record has been announced today, as the curtain raiser to the JP Morgan global Healthcare conference, with the news that Sanofi has acquired Kymab for $1.1bn with the possibility of further $350m milestone payments.

US investors flock to UK biotech as sector delivers strong outperformance in a turbulent 2020

Biotech companies on London stock markets delivered market-beating returns in 2020 and attracted new investors looking for growth in a turbulent year, according to new analysis published today by the UK BioIndustry Association (BIA) and Radnor Capital Partners.

BIA responds to publication of Rare Disease framework

Steve Bates OBE, Chief Executive of the BioIndustry Association (BIA) said: “We are very encouraged by the publication of the Rare Disease Framework and in particular its focus on ensuring patient access to treatments. Science continues to advance and to deliver new treatments for rare diseases where no treatment has been available before.

BIA reacts to trade deal agreement between UK and EU

Steve Bates OBE, Chief Executive of the BioIndustry Association said: "Today’s deal brings much desired certainty for our sector after four years of detailed negotiation.  We look forward to examining the full text in detail." 

Steve Bagshaw (FUJIFILM Diosynth Biotechnologies) and the BIA COVID-19 Vaccine Manufacturing Taskforce recognised at bioProcessUK conference

Steve Bagshaw, Chairman of FUJIFILM Diosynth Biotechnologies and the BIA COVID-19 vaccine manufacturing taskforce,  were awarded the prestigious Peter Dunnill award and Richard Wilson impact award respectively, at the UK BioIndustry Association’s (BIA) 17th bioProcessUK conference, which was held virtually on the 01 and 02 December.

BIA launches report on rare disease medicines appraisal

The BioIndustry Association's Rare Disease Industry Group (RDIG) has today launched A Rare Chance for Reform in collaboration with PwC, calling for action to ensure that patients are able to access innovative medicines for rare diseases.

Squeezed government biomedical innovation budget puts future medicines at risk, FOI reveals  

Insufficient government funding is putting the UK’s pipeline of future biomedical innovations at risk, according to data revealed in a Freedom of Information (FOI) request.  

Government confirms R&D tax credit cap exemption to protect genuine biotech companies

Draft legislation to implement the SME R&D tax credit PAYE cap published yesterday (12 November) confirms that the Government intends to implement a targeted exemption to protect genuine companies, as proposed by the BIA.

BIA responds to the publication of the NICE Methods Review consultation paper

Responding to the publication of a consultation paper on the National Institute for Health and Care Excellence (NICE) Methods following a review, Steve Bates OBE, Chief Executive of the Bioindustry Association said: